Patents by Inventor Dorothea Maetzel

Dorothea Maetzel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • FLT3 AGONIST ANTIBODIES AND USES THEREOF
    Publication number: 20220025055
    Abstract: Described herein are anti-FLT3 agonistic antibodies. Such agonistic antibodies are useful for the expansion of dendritic cells and the treatment of cancer.
    Type: Application
    Filed: December 17, 2019
    Publication date: January 27, 2022
    Inventors: Arif JETHA, Phil GOBEIL, Melissa BEILSCHMIDT, Dorothea MAETZEL, Johan FRANSSON
  • SPECIFIC PROTEASE INHIBITORS AND THEIR USE IN CANCER THERAPY
    Publication number: 20100226922
    Abstract: The present invention relates to a pharmaceutical composition comprising at least one inhibitor of EpCAM cleavage and at least one anti-EpCAM antibody, the use of least one inhibitor of EpCAM cleavage and at least one anti-EpCAM antibody for the manufacture of a medicament for the treatment and/or prevention of cancer, an in vitro method of inhibiting cancer by inhibiting cleavage of EpCAM, the use of a TACE inhibitor and/or a presenilin-2 inhibitor for inhibiting EpCAM cleavage, and a method of identifying a compound useful as an anti-cancer agent.
    Type: Application
    Filed: June 8, 2007
    Publication date: September 9, 2010
    Inventors: Dorothea Maetzel, Markus Muenz, Olivier Gires